TCGX SCHEDULE 13G: SEC filing
Biotechnology Value Fund entities and Mark N. Lampert
Filed with the SEC on · accession 0000921895-26-002072
TCGX filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 12, 2026. Biotechnology Value Fund entities and Mark N. The stock moved +16.2% by the first close after the filing.
Summary of the filing
Biotechnology Value Fund entities and Mark N. Lampert filed a Schedule 13G joint filing agreement regarding their beneficial ownership of Class A ordinary shares of TCGX Acquisition Corp. The filing indicates passive ownership by the BVF group.
Key details
How TCGX stock reacted
Close before
$14.42
Aug 11, 2026
First close after
+16.23%
$16.76
5 trading days
-2.91%
$14.00
Since filing
-30.37%
$10.04
✦ Ask GOAX AI about this filing — what it means for TCGX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TCGX?
Click hereFrequently asked questions
What did TCGX file with the SEC on Aug 12, 2026?
TCGX filed a SCHEDULE 13G (SEC filing). Biotechnology Value Fund entities and Mark N. Lampert filed a Schedule 13G joint filing agreement regarding their beneficial ownership of Class A ordinary shares of TCGX Acquisition Corp. The filing indicates passive ownership by the BVF group.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did TCGX stock react to this filing?
TCGX closed at $14.42 before the filing and $16.76 on Aug 12, 2026 (+16.23%). Five trading days later: $14.00 (-2.91%).
Other TCGX SEC filings
Get alerts when TCGX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days